BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34557802)

  • 1. Centralized multidisciplinary team assessment of metastasis resectability in patients with metastatic colorectal cancer: A fundamental necessity.
    André T
    Lancet Reg Health Eur; 2021 Apr; 3():100058. PubMed ID: 34557802
    [No Abstract]   [Full Text] [Related]  

  • 2. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
    Isoniemi H; Uutela A; Nordin A; Lantto E; Kellokumpu I; Ovissi A; Kosunen J; Kallio R; Soveri LM; Salminen T; Ålgars A; Lamminmäki A; Halonen P; Ristamäki R; Räsänen J; Karjula H; Vaalavuo Y; Lavonius M; Osterlund P
    Br J Surg; 2021 Jul; 108(7):817-825. PubMed ID: 33749772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study.
    Osterlund P; Salminen T; Soveri LM; Kallio R; Kellokumpu I; Lamminmäki A; Halonen P; Ristamäki R; Lantto E; Uutela A; Osterlund E; Ovissi A; Nordin A; Heervä E; Lehtomäki K; Räsänen J; Murashev M; Aroviita L; Jekunen A; Lindvall-Andersson R; Nyandoto P; Kononen J; Lepistö A; Poussa T; Muhonen T; Ålgars A; Isoniemi H;
    Lancet Reg Health Eur; 2021 Apr; 3():100049. PubMed ID: 34557799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study).
    Lehtomäki K; Soveri LM; Osterlund E; Lamminmäki A; Uutela A; Heervä E; Halonen P; Stedt H; Aho S; Muhonen T; Ålgars A; Salminen T; Kallio R; Nordin A; Aroviita L; Nyandoto P; Kononen J; Glimelius B; Ristamäki R; Isoniemi H; Osterlund P
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre study of multidisciplinary team assessment of pancreatic cancer resectability and treatment allocation.
    Kirkegård J; Aahlin EK; Al-Saiddi M; Bratlie SO; Coolsen M; de Haas RJ; den Dulk M; Fristrup C; Harrison EM; Mortensen MB; Nijkamp MW; Persson J; Søreide JA; Wigmore SJ; Wik T; Mortensen FV
    Br J Surg; 2019 May; 106(6):756-764. PubMed ID: 30830974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-World Perspectives From Surgeons and Oncologists on Resectability Definition and Multidisciplinary Team Discussion of Stage III NSCLC in People's Republic of China, Hong Kong, and Macau: A Physician Survey.
    Lee VH; Au JSK; Mu JW; Xiao G; Lim FMY; Suen HC; Wong KH
    JTO Clin Res Rep; 2022 May; 3(5):100308. PubMed ID: 35434668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.
    Hughes K; Pinsky CM; Petrelli NJ; Moffat FL; Patt YZ; Hammershaimb L; Goldenberg DM
    Ann Surg; 1997 Nov; 226(5):621-31. PubMed ID: 9389396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chinese expert consensus on multidisciplinary treatment of bone metastasis from colorectal cancer (2020 version)].
    Colorectal Oncology Committee of Chinese Medical Doctor Association
    Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):433-437. PubMed ID: 32575936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Multidisciplinary Team Discussion Intervention on the Prognosis of Advanced Colorectal Cancer.
    Zhang H; Yu J; Wei Z; Wu W; Zhang C; He Y
    J Cancer; 2021; 12(11):3307-3314. PubMed ID: 33976740
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Liver-first' approach for metastatic colorectal cancer.
    Donati M; Stavrou GA; Stang A; Basile F; Oldhafer KJ
    Future Oncol; 2015; 11(8):1233-43. PubMed ID: 25832880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical and Interventional Management of Lung Metastasis: Surgical Assessment, Resection, Ablation, Percutaneous Interventions.
    Stefanou AJ
    Clin Colon Rectal Surg; 2024 Mar; 37(2):85-89. PubMed ID: 38322599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the multidisciplinary tumor board (MDTB) in the assessment of pancreatic cancer diagnosis and resectability: A tertiary referral center experience.
    Quero G; De Sio D; Fiorillo C; Menghi R; Rosa F; Massimiani G; Laterza V; Lucinato C; Galiandro F; Papa V; Salvatore L; Bensi M; Tortorelli AP; Tondolo V; Alfieri S
    Front Surg; 2023; 10():1119557. PubMed ID: 36874464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taiwan Society of Colon and Rectal Surgeons (TSCRS) Consensus for Cytoreduction Selection in Metastatic Colorectal Cancer.
    Lin CC; Chen TH; Wu YC; Fang CY; Wang JY; Chen CP; Huang KW; Jiang JK
    Ann Surg Oncol; 2021 Mar; 28(3):1762-1776. PubMed ID: 32875464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening vs. non-screening detected colorectal cancer: Differences in pre-therapeutic work up and treatment.
    Saraste D; Martling A; Nilsson PJ; Blom J; Törnberg S; Janson M
    J Med Screen; 2017 Jun; 24(2):69-74. PubMed ID: 27470598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEOM clinical guidelines for diagnosis and treatment of metastatic colorectal cancer 2015.
    Aranda E; Aparicio J; Alonso V; Garcia-Albeniz X; Garcia-Alfonso P; Salazar R; Valladares M; Vera R; Vieitez JM; Garcia-Carbonero R
    Clin Transl Oncol; 2015 Dec; 17(12):972-81. PubMed ID: 26669312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical Resection of Colorectal Liver Metastases: Attitudes and Practice Patterns in the Deep South.
    Fonseca AL; Payne IC; Wong SL; Tan MCB
    J Gastrointest Surg; 2022 Apr; 26(4):782-790. PubMed ID: 34647225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
    Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
    Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3.
    Modest DP; Denecke T; Pratschke J; Ricard I; Lang H; Bemelmans M; Becker T; Rentsch M; Seehofer D; Bruns CJ; Gebauer B; Modest HI; Held S; Folprecht G; Heinemann V; Neumann UP
    Eur J Cancer; 2018 Jan; 88():77-86. PubMed ID: 29195117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially resectable metastatic colorectal cancer: an individualized approach to conversion therapy.
    Marino D; Leone F; D'Avanzo F; Ribero D; Capussotti L; Aglietta M
    Crit Rev Oncol Hematol; 2014 Dec; 92(3):218-26. PubMed ID: 24985058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standardized diagnosis and treatment of colorectal liver metastasis].
    Yao H; Zhang Z
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jul; 20(7):753-757. PubMed ID: 28722087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.